213 related articles for article (PubMed ID: 29220529)
21. [Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs].
Sterkenburg AS; Hoffmann A; Gebhardt U; Waldeck E; Springer S; Müller HL
Klin Padiatr; 2014 Nov; 226(6-7):344-50. PubMed ID: 25431867
[TBL] [Abstract][Full Text] [Related]
22. Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement.
Daubenbüchel AM; Özyurt J; Boekhoff S; Warmuth-Metz M; Eveslage M; Müller HL
Pediatr Obes; 2019 Sep; 14(9):e12527. PubMed ID: 31013553
[TBL] [Abstract][Full Text] [Related]
23. Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis.
Daubenbüchel AM; Hoffmann A; Gebhardt U; Warmuth-Metz M; Sterkenburg AS; Müller HL
Eur J Endocrinol; 2015 May; 172(5):561-9. PubMed ID: 25650403
[TBL] [Abstract][Full Text] [Related]
24. Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Miao Y; Fan K; Peng X; Li S; Chen J; Bai RN; Wei Y; Deng Y; Zhao C; Wu Q; Ge M; Gong J; Wu D
Front Endocrinol (Lausanne); 2023; 14():1241145. PubMed ID: 38027203
[TBL] [Abstract][Full Text] [Related]
25. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
[TBL] [Abstract][Full Text] [Related]
26. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.
Ismail D; O'Connell MA; Zacharin MR
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):129-34. PubMed ID: 16562585
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Roth CL; Zenno A
Front Endocrinol (Lausanne); 2023; 14():1256514. PubMed ID: 37780616
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients.
Müller HL
Minerva Endocrinol; 2017 Dec; 42(4):356-375. PubMed ID: 28181780
[TBL] [Abstract][Full Text] [Related]
29. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.
de Vile CJ; Grant DB; Hayward RD; Kendall BE; Neville BG; Stanhope R
J Clin Endocrinol Metab; 1996 Jul; 81(7):2734-7. PubMed ID: 8675604
[TBL] [Abstract][Full Text] [Related]
30. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy.
Inge TH; Pfluger P; Zeller M; Rose SR; Burget L; Sundararajan S; Daniels SR; Tschöp MH
Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):606-9. PubMed ID: 17643131
[TBL] [Abstract][Full Text] [Related]
31. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance.
Maniatis AK; Simmons JH; Zeitler PS
Curr Opin Pediatr; 2005 Apr; 17(2):275-9. PubMed ID: 15800425
[No Abstract] [Full Text] [Related]
32. Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma.
Müller HL; Faldum A; Etavard-Gorris N; Gebhardt U; Oeverink R; Kolb R; Sörensen N
Klin Padiatr; 2003; 215(6):310-4. PubMed ID: 14677094
[TBL] [Abstract][Full Text] [Related]
33. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.
Mason PW; Krawiecki N; Meacham LR
Arch Pediatr Adolesc Med; 2002 Sep; 156(9):887-92. PubMed ID: 12197795
[TBL] [Abstract][Full Text] [Related]
34. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma.
Schultes B; Ernst B; Schmid F; Thurnheer M
Eur J Endocrinol; 2009 Jul; 161(1):201-6. PubMed ID: 19411299
[TBL] [Abstract][Full Text] [Related]
35. Hypothalamic obesity in children.
Bereket A; Kiess W; Lustig RH; Muller HL; Goldstone AP; Weiss R; Yavuz Y; Hochberg Z
Obes Rev; 2012 Sep; 13(9):780-98. PubMed ID: 22577758
[TBL] [Abstract][Full Text] [Related]
36. The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort.
van Iersel L; Meijneke RWH; Schouten-van Meeteren AYN; Reneman L; de Win MM; van Trotsenburg ASP; Bisschop PH; Finken MJJ; Vandertop WP; van Furth WR; van Santen HM
Pediatr Blood Cancer; 2018 May; 65(5):e26911. PubMed ID: 29314661
[TBL] [Abstract][Full Text] [Related]
37. Outcome of Radical Surgical Resection for Craniopharyngioma with Hypothalamic Preservation: A Single-Center Retrospective Study of 1054 Patients.
Shi X; Zhou Z; Wu B; Zhang Y; Qian H; Sun Y; Yang Y; Yu Z; Tang Z; Lu S
World Neurosurg; 2017 Jun; 102():167-180. PubMed ID: 28254603
[TBL] [Abstract][Full Text] [Related]
38. Endocrine Disorders Developing after Surgical Intervention of Craniopharyngioma in Children.
Shohdy KS; Rashad W
Pediatr Endocrinol Rev; 2017 Mar; 14(3):298-301. PubMed ID: 28508600
[TBL] [Abstract][Full Text] [Related]
39. First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma.
Hoffmann A; Özyurt J; Lohle K; Reichel J; Thiel CM; Müller HL
Endocrine; 2017 Apr; 56(1):175-185. PubMed ID: 28213803
[TBL] [Abstract][Full Text] [Related]
40. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases.
Zoicas F; Droste M; Mayr B; Buchfelder M; Schöfl C
Eur J Endocrinol; 2013 May; 168(5):699-706. PubMed ID: 23392214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
